EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische StudieOpen Access · CC BY-NC-ND 4.0

Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group

Herbert Pichler iD, Petr Sedlacek, Roland Meisel, Rita Beier, Maura Faraci iD, Krzysztof Kalwak, Marianne Ifversen iD, Ingo Müller, Jerry Stein, Kim Vettenranta, Gabriele Kropshofer, Alexandra Kolenova und 7 weitere

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19535 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Herbert Pichler und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Haematology and Oncology, St. Anna Children's Hospital, Vienna, Austria. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Transplantation Conditioning, Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This prospective multicentre trial evaluated the safety and the efficacy of a thiotepa/melphalan‐based reduced intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT) in children and adolescents with chronic myeloid leukaemia (CML) in chronic phase (CP). Thirty‐two patients were transplanted from matched siblings or matched unrelated donors. In 22 patients, HSCT was performed due to insufficient molecular response or loss of response to first‐ or second‐generation tyrosine kinase inhibitor (TKI), with pretransplant BCR::ABL1 transcripts ranging between 0.001% and 33%. The protocol included a BCR::ABL1 ‐guided intervention with TKI retreatment in the first year and donor lymphocyte infusions (DLI) in the second‐year post‐transplant. All patients engrafted. The 1‐year transplant‐related mortality was 3% (confidence interval [CI]: 0%–6%). After a median follow‐up of 6.3 years, 5‐year overall survival and event‐free survival are 97% (CI: 93%–100%) and 91% (CI: 79%–100%) respectively. The current 5‐year leukaemia‐free survival with BCR::ABL1

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationTransplantation ConditioningLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHumansAdolescentChildMaleFemaleChild, PreschoolProspective StudiesGraft vs Host DiseaseTreatment OutcomeProtein Kinase Inhibitors

Stichwörter der Autor:innen

allogeneic stem cell transplantationchildren and adolescentschronic myeloid leukaemiareduced intensity conditioning

Substanzen

Protein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Paediatric Haematology and Oncology, St. Anna Children's Hospital, Vienna, Austria.
  • Department of Paediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
  • Children's Cancer Research Institute, Medical University of Vienna, Vienna, Austria.
  • Department of Paediatric Haematology and Oncology, University Hospital Motol, Charles University, Prague, Czech Republic.
  • Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.
  • Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.

ORCID-Profile: Herbert Pichler, Maura Faraci, Marianne Ifversen, Christina Peters, Meinolf Suttorp

Zitieren

APA

Pichler, H., Sedlacek, P., Meisel, R., Beier, R., Faraci, M., Kalwak, K., Ifversen, M., Müller, I., Stein, J., Vettenranta, K., Kropshofer, G., Kolenova, A., Karlhuber, S., Glogova, E., Poetschger, U., Peters, C., Suttorp, M., Matthes-Leodolter, S., & Balduzzi, A. (2024). Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group. British Journal of Haematology. https://doi.org/10.1111/bjh.19535

Vancouver

Pichler H, Sedlacek P, Meisel R, Beier R, Faraci M, Kalwak K, et al. Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group. British Journal of Haematology. 2024. doi:10.1111/bjh.19535

BibTeX
@article{Pichler2024,
  author = {Pichler, Herbert and Sedlacek, Petr and Meisel, Roland and Beier, Rita and Faraci, Maura and Kalwak, Krzysztof and Ifversen, Marianne and Müller, Ingo and Stein, Jerry and Vettenranta, Kim and Kropshofer, Gabriele and Kolenova, Alexandra and Karlhuber, Susanne and Glogova, Evgenia and Poetschger, Ulrike and Peters, Christina and Suttorp, Meinolf and Matthes-Leodolter, Susanne and Balduzzi, Adriana},
  title = {Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19535}
}
Kostenlos starten →